Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome

NCT00527566 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Churg Strauss Syndrome

Interventions

BIOLOGICAL: Mepolizumab

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]